Injectable Nanomedicines Market

Injectable Nanomedicines Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment; 2018 - 2028

  • Ongoing
  • February 2020
  • REP-GB-7993
  • PDF PPT EXCEL
Injectable Nanomedicines Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Injectable Nanomedicines market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Injectable Nanomedicines market.


Nanomedicines belong to a niche field - where nanotechnology is combined with pharmaceuticals and other biomedical sciences. Injectable nanomedicines, if manufactured properly, can emerge as medicines with higher efficacy and safer toxicology profiles. Injectable nanomedicines can be a functional in many clinical cases for drug delivery and drug formulation. Currently nanomedicines account for a small revenue share in the entire nanotechnology based nanomaterial market- as nanomaterial is used in most of the working sectors. The rise of injectable nanomedicines is projected to lead to better outcomes and medicines for therapeutic areas such as cancer, CNS disease, cardiovascular disease and infection control. Nanotechnology is used in in vivo imaging, in vitro diagnostics, active implants and biomaterials.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Need granular data and specific insights that are hard to get?

Injectable Nanomedicines Market: Drivers and Restraints

Primary revenue drivers of the injectable nanomedicines market are increasing usage as delivery vectors and probes for biological diagnostics, imaging and therapeutics given their extremely small size. The smaller the surface area, the larger is the space available for chemical interaction with biomolecules. Increased focus on selective drug delivery and targeted therapies is another important factor booting demand for injectable nanomedicines. These medicines are witnessing high demand in research pertaining to regenerative medicines and in-situ tissue regeneration. Restraints of the market include lack of adequate sterile manufacturing facilities and process knowledge in developing markets. Another critical factor, which is expected to dampen market outlook is increasing availability and market penetration of cheaper generics, both in developed and developing markets. Few other factors that could suppress revenue expansion in injectable nanomedicines market are long drug approval timelines from regulatory authorities, large requirement of capital and shrinking R&D budgets of drugmakers.

Injectable Nanomedicines Market: Overview

The global market for Injectable Nanomedicines is niche with few drugs currently approved but a large attractive drug pipeline. Increased focus towards targeted medicines for personalized therapies is fuelling the demand for these injectable nanomedicines. Developed markets hold the largest revenue expansion potential as compared to emerging markets. Developing product and process know-how coupled with participation of patients actively in treatment seeking process are factors projected to increase the demand for injectable nanomedicines. Rising availability and accessibility to cheaper generics is a factor that poses serious competition to R&D and sales for these expensive drugs. The injectable nanomedicines market is estimated to expand at a significant CAGR over the forecast period with developed markets outweighing the market share by revenues derived. Increased adoption of personalized treatments for infectious diseases, cancers and autoimmune diseases to benefit the patient population is aiding the market entry of injectable nanomedicines. 

Injectable Nanomedicines Market: Regional Wise Outlook

Geographically, the Injectable Nanomedicines Market is classified into eight regions viz. North America, Western Europe, Eastern Europe, Latin America, Asia-Pacific Excluding China and Japan, Japan, China, Middle East and Africa. The North America market is estimated to account for a significant market share by drug sales bestowed with availability of progressive healthcare facilities, increased focus on disease surveillance and availability of skilled manpower for drug R&D. Availability of large GMP certified sterile manufacturing facilities both in-house and through contract manufacturers are factors that increase the revenue attractiveness of Western European markets – estimated  to emerge as the second largest market for injectable nanomedicines. Markets in Asia Pacific region are expected to grow rapidly owing to high demand emanating from presence of infectious diseases in the region. Japan and China markets are expected to expand rapidly in revenue generation owing to greater focus on drug R&D and availability of fast track approval processes from relevant regulatory authorities for Injectable Nanomedicines throughout the forecast period.

Injectable Nanomedicines Market: Key Players

Some of the major players in the global Injectable Nanomedicines Market are Merck & Co., Inc., Osartis GmbH & Co. KG, Wyeth Pharmaceuticals Inc., Orthovita, Inc., Novartis, Abbott, Pacira Pharmaceuticals, QLT Phototherapeutics, Celgene Pharmaceutical Co. Ltd., and Amgen, Inc.,. Transparency in R&D and resorting to fast track drug approval processes are key strategies being followed by leading players in the injectable nanomedicines market to minimize costing and time to market.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The injectable nanomedicines market report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
  • Drug Pipeline Analysis
  • Regulatory Overview

Regional analysis of the injectable nanomedicines market report includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Rest of Western Europe)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan and China (India, Australia & New Zealand, ASEAN, Rest of APEJC)
  • Japan
  • China
  • Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Injectable Nanomedicines Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Injectable Nanomedicines Market: Segmentation

Tentatively, the global Injectable Nanomedicines Market has been segmented on the basis of product type, application type, end user and geography.

Based on drug type, the global Injectable Nanomedicines market is segmented as:

  • Liposomes
  • Micelles
  • Nanocrystals
  • Polymeric Nanoparticles
  • Metallic Nanoparticles
  • Mesoporous Silica Nanoparticles
  • Others

Based on application, injectable nanomedicines market is segmented as:

  • Cancers
  • Central Nervous System Diseases
  • Cardiovascular diseases
  • Infection Control
  • Inflammatory Diseases
  • Others

Based on end user, the global Injectable Nanomedicines market is segmented as:

  • Hospitals
  • Ambulatory Surgical Center
  • Clinics
  • Specialized Drug R&D institutes
  • Managed Care Organizations

Injectable Nanomedicines Market Report Highlights:

  • Overview of Global Pharmaceutical Market
  • Evolution of Nanomedicines
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology